How and Why to Involve Patients in Drug Development: Perspectives From the Pharmaceutical Industry, Regulatory Authorities, and Patient Organizations.

Hansen, Marianne Botoft; Nørgaard, Lotte Stig; Hallgreen, Christine Erikstrup

Hansen, Marianne Botoft; Nørgaard, Lotte Stig; Hallgreen, Christine Erikstrup.

Affiliation

Hansen MB; Copenhagen Centre for Regulatory Science, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen Ø, DK-2100, Denmark.
Nørgaard LS; Social and Clinical Pharmacy, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Hallgreen CE; Copenhagen Centre for Regulatory Science, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen Ø, DK-2100, Denmark. christine.hallgreen@sund.ku.dk.

Ther Innov Regul Sci ; 54(3): 577-585, 2020 05.

Article in En | MEDLINE | ID: mdl-33301145

Subject(s)

Pharmaceutical Preparations; Quality of Life; Drug Industry; Humans; Patient Participation; Qualitative Research

Key words

Patient involvement; drug development; patient engagement; qualitative; regulatory science; social constructivism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Pharmaceutical Preparations Type of study: Prognostic_studies / Qualitative_research Limits: Humans Language: En Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google